Alliance for Biosecurity and Industry: Congressional Leaders Must Reauthorize PAHPA in 2024

Joins Over 115 Organizations in Calling for Bipartisan Reauthorization

WASHINGTON, D.C. – The Alliance for Biosecurity joined a letter to Speaker of the House Mike Johnson (R-LA), Senate Majority Leader Chuck Schumer (D-NY), House Democratic Leader Hakeem Jeffries (D-NY), and Senate Republican Leader Mitch McConnell (R-KY) in support of the urgent bipartisan reauthorization of the Pandemic and All-Hazards Preparedness Act (PAHPA). The letter, signed by over 115 organizations, including Alliance for Biosecurity member companies Bavarian Nordic, Emergent BioSolutions, GSK, Nighthawk Biosciences, and SIGA Technologies, industry organizations call on Congress to prioritize passage of this critical legislation. “Failing to reauthorize PAHPA would have serious effects on our country’s economic wellbeing, national security, and health security given the rapidly changing threat landscape,” the letter reads.  

In response to the letter, Senate Health, Education, Labor and Pensions (HELP) Committee Ranking Member Bill Cassidy (R-LA) said, “providing a strong PAHPA framework is crucial to improving our readiness towards the next pandemic, natural disaster, attack, or accident that puts Americans’ health and safety at risk.”

The Alliance has consistently called on Congress to support critical biodefense programs and strong public-private partnerships that provide for the development, procurement, and stockpiling of lifesaving medical countermeasures (MCMs). The forthcoming reauthorization of PAHPA, the first since the COVID-19 Pandemic, is urgently needed to provide private industry with the programmatic certainty necessary to continue government partnerships that protect public health and enhance national health security.